Home Newsfeeds ‘Apple reportedly plans to put ads in more apps on your iPhone’ -CNBC Report

News

‘Apple reportedly plans to put ads in more apps on your iPhone’ -CNBC Report

https://www.cnbc.com/2022/08/15/apple-reportedly-plans-to-put-ads-in-more-apps-on-your-iphone.html#Echobox=1660574191

byBenzinga Newsdesk

August 15, 2022

1 minute read

https://www.cnbc.com/2022/08/15/apple-reportedly-plans-to-put-ads-in-more-apps-on-your-iphone.html#Echobox=1660574191

Huntington Ingalls Completes Sea Trials For US Coast Guard’s New Security Cutter

By Nabaparna Bhattacharya

July 3, 12:51 PM

Huntington Ingalls Industries, Inc. (NYSE: HII) declared the successful completion of sea trials for the U.S.

HII

Frontier Intends To Offer ~$750M Aggregate Principal Amount Of Secured Fiber Network Revenue Term Notes, With An Anticipated Repayment Date In May 2031

By Benzinga Newsdesk

June 3, 8:29 AM

Frontier Communications Parent, Inc. (NASDAQ:FYBR) ("Frontier" or the "Company") today announced that a limited-purpose, bankruptcy remote, indirect subsidiary of the Company intends to offer approximately $750 million

FYBR

News

Why BioSig Technologies (BSGM) Shares Are Down Over 60%

By Henry Khederian

June 11, 1:52 PM

BioSig Technologies shares are trading lower by 67% during Tuesday's session. The company said it was notified by the Nasdaq Hearings Panel that its common stock will be delisted.

BSGM

Morgan Stanley Upgrades Ionis Pharmaceuticals to Overweight, Raises Price Target to $57

By Benzinga Newsdesk

September 9, 7:59 AM

Morgan Stanley analyst Andrew Galler upgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Underweight to Overweight and raises the price target from $30 to $57.

IONS

‘Apple reportedly plans to put ads in more apps on your iPhone’ -CNBC Report

Related Posts

Huntington Ingalls Completes Sea Trials For US Coast Guard’s New Security Cutter

Frontier Intends To Offer ~$750M Aggregate Principal Amount Of Secured Fiber Network Revenue Term Notes, With An Anticipated Repayment Date In May 2031

Why BioSig Technologies (BSGM) Shares Are Down Over 60%

Morgan Stanley Upgrades Ionis Pharmaceuticals to Overweight, Raises Price Target to $57